Coating the plate with antibiotic cement to treat early infection after fracture fixation with retention of the implants: a technical note
- PMID: 30301459
- PMCID: PMC6178260
- DOI: 10.1186/s12891-018-2285-2
Coating the plate with antibiotic cement to treat early infection after fracture fixation with retention of the implants: a technical note
Abstract
Background: Local antibiotic therapy has gained increasing attraction in the prevention and treatment of fracture infection. However, no reports have used local antibiotic therapy in the management of early infection after fracture fixation with retention of implants.
Methods: The present surgical technique report the use of antibiotic impregnated bone cement in the management of early infection after fracture fixation. Initially, the fractures were fixed with plates. The average time from initial procedure to debridement was15 days (range 9 to 25 days). The infections were treated with irrigation, debridement, and retention of the implant. The lateral surface of the plates was coated with antibiotic cement and the bone defect was filled with antibiotic cement spacer after thorough debridement.
Results: Ten patients underwent this technique. The mean follow-up was 2.0 years (range 6 months to 4 years). The bone union rate was 100%, and the average time to bone healing was5.5 months.There was recurrence of infection in one patient before bone healing, but the implants were left in place until bone healed, and the infection was eradicated after implant removal.
Conclusion: Coating the plate with antibiotic cement is a simple technique which may play a role in the management of early infection after fracture fixation.
Keywords: Antibiotic impregnated bone cement; Fracture; Infection; Local antibiotic therapy.
Conflict of interest statement
Ethics approval and consent to participate
The study was authorized by the Medical Ethics Committee of Nanjing Drum Tower hospital (Ref. No. 115875). All patients or patient’s legal guardian gave written informed consent for inclusion in the study.
Consent for publication
Consent to publish was obtained for the patients or patient’s legal guardian whose information appears in this publication.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical